EUVIMEDEUVIMED entdecken
Crossref

Development of a ROS-responsive, glutathione-functionalized injectable hydrogel system for controlled drug release

Kai Hu, Linlin Liang, Jian Song iD

Journal of Biomaterials Applications · 2025

DOI: 10.1177/08853282251334208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomaterials Applications, 2025. Verfasst von Kai Hu und 2 weiteren Autor:innen. Beteiligte Einrichtung: The First School of Clinical Medicine, Southern Medical University, Wuhan, China. Hauptthemen laut MEDLINE: Delayed-Action Preparations, Hydrogels, Oxidative Stress. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxidative stress arises from an imbalance between excessive production of reactive oxygen species (ROS) and the body’s antioxidant defenses. In neurodegenerative diseases, this imbalance leads to ROS accumulation, causing neuronal dysfunction and cell death. Traditional drug therapies often fail to address the dynamic nature of neuroinflammation, limiting their therapeutic efficacy. To overcome this challenge, we have developed an innovative ROS-responsive injectable hydrogel. This hydrogel is designed to detect oxidative stress sensitively and release glutathione in a controlled manner, thereby modulating inflammation and restoring the damaged immune microenvironment to facilitate tissue repair. The hydrogel was synthesized by crosslinking polyvinyl alcohol (PVA) with sodium alginate modified with 3-aminophenylboronic acid (Alg-PBA). We investigated the hydrogel’s formation mechanism and analyzed how component variations affect its morphological and rheological properties. Our findings demonstrate that an optimal Alg-PBA to PVA weight ratio of 2:1 yields a hydrogel with superior mechanical strength. Glutathione (GSH) release studies confirmed the hydrogel’s pronounced ROS-responsive drug release behavior. Furthermore, biocompatibility assessments revealed that the hydrogel loaded with 100 μg/mL GSH exhibited excellent compatibility and significantly inhibited neuronal apoptosis under oxygen-glucose deprivation (OGD) conditions. This work presents a promising strategy for treating inflammation-related diseases and provides valuable insights for designing next-generation hydrogels that adapt to injury-responsive microenvironments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Delayed-Action PreparationsHydrogelsOxidative StressReactive Oxygen SpeciesGlutathioneInjectionsPolyvinyl AlcoholAlginatesBoronic AcidsBiocompatible MaterialsNeuroprotectionNeuronsAnimalsMiceCell Line

Stichwörter der Autor:innen

ROS-responsiveglutathioneinjectable hydrogelneurodegenerative diseasesneuroprotection

Substanzen

Delayed-Action PreparationsReactive Oxygen SpeciesGlutathioneHydrogelsPolyvinyl AlcoholAlginates3-aminobenzeneboronic acidBoronic AcidsBiocompatible Materials

Autor:innen und Institutionen

  • The First School of Clinical Medicine, Southern Medical University, Wuhan, China.
  • Beijing Institute of Basic Medical Sciences, Beijing, China.

ORCID-Profile: Jian Song

Zitieren

APA

Hu, K., Liang, L., & Song, J. (2025). Development of a ROS-responsive, glutathione-functionalized injectable hydrogel system for controlled drug release. Journal of Biomaterials Applications. https://doi.org/10.1177/08853282251334208

Vancouver

Hu K, Liang L, Song J. Development of a ROS-responsive, glutathione-functionalized injectable hydrogel system for controlled drug release. Journal of Biomaterials Applications. 2025. doi:10.1177/08853282251334208

BibTeX
@article{Hu2025,
  author = {Hu, Kai and Liang, Linlin and Song, Jian},
  title = {Development of a ROS-responsive, glutathione-functionalized injectable hydrogel system for controlled drug release},
  journal = {Journal of Biomaterials Applications},
  year = {2025},
  doi = {10.1177/08853282251334208}
}
Kostenlos starten →